Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Weber

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|April 1, 1986
Genetic differences in inhibition of 2-aminofluorene N-acetyltransferase activity between C57BL/6J and A/J miceT A Hultin, W W Weber
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1993
N-acetylation polymorphism in liver and pancreas of inbred ratsK J Martell, W W Weber
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1986
N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivoH H Andres, W W Weber
Pediatric Clinics of North America|February 1, 1972
PharmacogeneticsS N Cohen, W W Weber
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1980
Antinuclear antibodies related to acetylator phenotype in miceR H Tannen, W W Weber
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbitD W Hein, W W Weber
Pharmacogenetics|August 1, 1993
Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral bloodW W Weber, K P Vatsis
Carcinogenesis|December 1, 1987
Genetic variability in deacetylation of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in inbred strains of miceT A Hultin, W W Weber
Clinical Pharmacokinetics|November 1, 1979
Clinical pharmacokinetics of isoniazidW W Weber, D W Hein
Carcinogenesis|April 1, 1989
2-Aminofluorene-DNA adduct formation in acetylator congenic mouse linesG N Levy, W W Weber
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|April 1, 1986
Genetic differences in inhibition of 2-aminofluorene N-acetyltransferase activity between C57BL/6J and A/J miceT A Hultin, W W Weber
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1993
N-acetylation polymorphism in liver and pancreas of inbred ratsK J Martell, W W Weber
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1986
N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivoH H Andres, W W Weber
Pediatric Clinics of North America|February 1, 1972
PharmacogeneticsS N Cohen, W W Weber
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1980
Antinuclear antibodies related to acetylator phenotype in miceR H Tannen, W W Weber
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbitD W Hein, W W Weber
Pharmacogenetics|August 1, 1993
Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral bloodW W Weber, K P Vatsis
Carcinogenesis|December 1, 1987
Genetic variability in deacetylation of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in inbred strains of miceT A Hultin, W W Weber
Clinical Pharmacokinetics|November 1, 1979
Clinical pharmacokinetics of isoniazidW W Weber, D W Hein
Carcinogenesis|April 1, 1989
2-Aminofluorene-DNA adduct formation in acetylator congenic mouse linesG N Levy, W W Weber
Pageof 10